Patents by Inventor Lynn E. Clark

Lynn E. Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883106
    Abstract: A method for determining a predicted lesion size formed in a tissue by receiving or calculating a measure of contact force between the electrode and the tissue, determining a tissue characterization, and calculating the predicted lesion size using both the measure of contact force and the tissue characterization. A system comprising an electronic control unit configured to receive or determine a measure of contact force between the electrode and the tissue, characterize the tissue based on both the measure of impedance and the measure of contact force, and cause the tissue characterization to be either (a) presented to a user, or (b) applied to calculate a metric and cause the metric to be presented to the user.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: January 30, 2024
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventors: Jeffrey M. Fish, Lynn E. Clark
  • Patent number: 10194885
    Abstract: A system that automatically detects a myocardial barotrauma (i.e., tissue pop) event so that proper post-procedure care can be given includes an electronic control unit (ECU), a computer-readable memory coupled with the ECU, and detection logic stored in the memory configured to be executed by the ECU. The detection logic is configured to receive a signal generated by an electro-acoustic transducer related to acoustic activity within the patient, monitor the signal for a pre-determined indication of a barotrauma event, and output a notification when the pre-determined indication is detected. The transducer can be integrated with an extra-body patch that includes one or more electrodes for use with a medical device navigation system.
    Type: Grant
    Filed: October 2, 2012
    Date of Patent: February 5, 2019
    Assignee: ST. JUDE MEDICAL, ATRIAL FIBRILLATION DIVISION, INC.
    Inventors: Israel A. Byrd, Jeffrey M. Fish, Lynn E. Clark, Saurav Paul
  • Publication number: 20170319279
    Abstract: A method for determining a predicted lesion size formed in a tissue by receiving or calculating a measure of contact force between the electrode and the tissue, determining a tissue characterization, and calculating the predicted lesion size using both the measure of contact force and the tissue characterization. A system comprising an electronic control unit configured to receive or determine a measure of contact force between the electrode and the tissue, characterize the tissue based on both the measure of impedance and the measure of contact force, and cause the tissue characterization to be either (a) presented to a user, or (b) applied to calculate a metric and cause the metric to be presented to the user.
    Type: Application
    Filed: May 1, 2017
    Publication date: November 9, 2017
    Inventors: Jeffrey M. Fish, Lynn E. Clark
  • Patent number: 9610119
    Abstract: A method and system for assessing lesion formation in tissue is provided. The system includes an electronic control unit (ECU) configured to acquire magnitudes for a component of a complex impedance between an electrode and tissue, and the power applied to the tissue during lesion formation. The ECU is configured to calculate a value responsive to the complex impedance component and the power. The value is indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, or a predicted tissue temperature. The method includes acquiring magnitudes for a component of a complex impedance between an electrode and tissue and the power applied during lesion formation. The method includes calculating a value responsive to the complex impedance component and the power, the value being indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, and/or a predicted tissue temperature.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: April 4, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Harry A. Puryear, Saurav Paul
  • Publication number: 20140358038
    Abstract: A system that automatically detects a myocardial barotrauma (i.e., tissue pop) event so that proper post-procedure care can be given includes an electronic control unit (ECU), a computer-readable memory coupled with the ECU, and detection logic stored in the memory configured to be executed by the ECU. The detection logic is configured to receive a signal generated by an electro-acoustic transducer related to acoustic activity within the patient, monitor the signal for a pre-determined indication of a barotrauma event, and output a notification when the pre-determined indication is detected. The transducer can be integrated with an extra-body patch that includes one or more electrodes for use with a medical device navigation system.
    Type: Application
    Filed: October 2, 2012
    Publication date: December 4, 2014
    Inventors: Israel A. Byrd, Jeffrey M. Fish, Lynn E. Clark, Saurav Paul
  • Publication number: 20140194867
    Abstract: A method and system for assessing lesion formation in tissue is provided. The system includes an electronic control unit (ECU) configured to acquire magnitudes for a component of a complex impedance between an electrode and tissue, and the power applied to the tissue during lesion formation. The ECU is configured to calculate a value responsive to the complex impedance component and the power. The value is indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, or a predicted tissue temperature. The method includes acquiring magnitudes for a component of a complex impedance between an electrode and tissue and the power applied during lesion formation. The method includes calculating a value responsive to the complex impedance component and the power, the value being indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, and/or a predicted tissue temperature.
    Type: Application
    Filed: November 22, 2013
    Publication date: July 10, 2014
    Applicant: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Harry A. Puryear, Saurav Paul
  • Publication number: 20130338467
    Abstract: An electrode catheter device with indifferent electrode for direct current tissue therapies is disclosed. An example of the catheter device has a flexible tubing with at least one ablation electrode. The catheter device also may also be used with a sheath for introducing the flexible tubing inside a patient's body. An indifferent electrode on the sheath can provide a ground for a direct current (DC) pulse to deliver electrical energy and create an electrical field adjacent a tissue. Various other embodiments are also disclosed.
    Type: Application
    Filed: November 18, 2011
    Publication date: December 19, 2013
    Applicant: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Martin M. Grasse, Richard E. Stehr, Israel A. Byrd, Lynn E. Clark, D. Curtis Deno, Troy T. Tegg, James V. Kauphusman, Saurav Paul, Jeffrey A. Schweitzer
  • Patent number: 8603084
    Abstract: A method and system for assessing lesion formation in tissue is provided. The system includes an electronic control unit (ECU) configured to acquire magnitudes for a component of a complex impedance between an electrode and tissue, and the power applied to the tissue during lesion formation. The ECU is configured to calculate a value responsive to the complex impedance component and the power. The value is indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, or a predicted tissue temperature. The method includes acquiring magnitudes for a component of a complex impedance between an electrode and tissue and the power applied during lesion formation. The method includes calculating a value responsive to the complex impedance component and the power, the value being indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, and/or a predicted tissue temperature.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: December 10, 2013
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Harry A. Puryear, Saurav Paul
  • Publication number: 20110144657
    Abstract: A method and system for determining a likelihood of barotrauma occurring in tissue during the formation of a lesion therein is provided. The system includes an electronic control unit (ECU). The ECU is configured to acquire at least one value of at least one component of a complex impedance between an electrode and the tissue. The ECU is further configured to calculate an index responsive to the at least one value of the at least one complex impedance component. The index is indicative of a likelihood of barotrauma occurring in the tissue. The method comprises acquiring at least one value of at least one component of a complex impedance between an electrode and the tissue. The method further comprises calculating an index responsive to the at least one value of the at least one complex impedance component. The calculating index is indicative of a likelihood of barotrauma occurring in the tissue.
    Type: Application
    Filed: December 10, 2010
    Publication date: June 16, 2011
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Rohan Lathia, Harry A. Puryear, Valtino X. Afonso, Saurav Paul
  • Publication number: 20110118727
    Abstract: A method and system for assessing lesion formation in tissue is provided. The system includes an electronic control unit (ECU) configured to acquire magnitudes for a component of a complex impedance between an electrode and tissue, and the power applied to the tissue during lesion formation. The ECU is configured to calculate a value responsive to the complex impedance component and the power. The value is indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, or a predicted tissue temperature. The method includes acquiring magnitudes for a component of a complex impedance between an electrode and tissue and the power applied during lesion formation. The method includes calculating a value responsive to the complex impedance component and the power, the value being indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, and/or a predicted tissue temperature.
    Type: Application
    Filed: November 16, 2010
    Publication date: May 19, 2011
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Harry A. Puryear, Saurav Paul